MiMedx Group, Inc. (MDXG) NASDAQ
3.43
+0.08(+2.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.43
+0.08(+2.39%)
Currency In USD
| Previous Close | 3.35 |
| Open | 3.34 |
| Day High | 3.5 |
| Day Low | 3.29 |
| 52-Week High | 7.99 |
| 52-Week Low | 3.19 |
| Volume | 1.69M |
| Average Volume | 1.17M |
| Market Cap | 509.58M |
| PE | 10.72 |
| EPS | 0.32 |
| Moving Average 50 Days | 4.3 |
| Moving Average 200 Days | 6.12 |
| Change | 0.08 |
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields
GlobeNewswire Inc.
Mar 05, 2026 1:00 PM GMT
Bolsters Surgical offering with product specifically designed for use in endocrine proceduresMARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of AM
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
GlobeNewswire Inc.
Feb 17, 2026 1:00 PM GMT
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 afte
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
GlobeNewswire Inc.
Feb 04, 2026 3:27 PM GMT
Agreement expands offering to include additional sheet, particulate and flowable productsMARIETTA, Ga., Feb. 04, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it has entered into an exclusive